CureVac NV (XTER:5CV)
€ 2.912 -0.018 (-0.61%) Market Cap: 667.92 Mil Enterprise Value: 500.70 Mil PE Ratio: 0 PB Ratio: 1.83 GF Score: 47/100

CureVac NV Annual Shareholders Meeting Transcript

Mar 28, 2023 / NTS GMT
Release Date Price: €5.88 (-5.53%)
Hans Christoph Tanner
CureVac N.V. - Independent Supervisory Board Member

Ladies and gentlemen, welcome to the Extraordinary General Meeting of Shareholders of CureVac N.V. My name is Chris Tanner. I'm the Chairman of the Audit Committee and a member of the Supervisory Board of CureVac NV. I've been appointed by Jean Stéphenne, the Chairman of our Supervisory Board, to chair today's extraordinary general meeting on his behalf. First, allow me to introduce Dr. Alexander Zehnder, who's been nominated for appointment as Managing Director and Chief Executive Officer, at this meeting; and Dr. Myriam Mendila, who has been nominated for appointment as Managing Director and Chief Development Officer at this meeting. Dr. Zehnder and Dr. Mendila will have the opportunity of introducing themselves to you when it's time to vote on their respective appointments.

Also present in person today are Dr. Franz-Werner Haas, our outgoing CEO; Dr. Marco Rau, our General Counsel, who will act as Secretary of today's meeting; and our Dutch Notary, (inaudible).

Before proceeding, I will now give the floor to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot